{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01435",
      "entity_text" : "aminotransferases",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_Y548" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ]
    }
  },
  "verbose_text" : "Serious treatment related adverse events were reported in five patients (6%), namely, enterocolitis, infusion related reaction, increase in levels of aminotransferases, chondrocalcinosis, synovitis and interstitial nephritis; five grade 3 treatment related adverse events occurred in four (5%) patients, namely, lymphopenia in two patients, blood creatine phosphokinase increase in one patient, aminotransferase increase in one patient, and blood cholesterol increase in one patient.",
  "reading_complete" : "2020-08-04T12:10:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:00:15Z",
  "trigger" : "levels",
  "evidence" : [ "levels of aminotransferases" ],
  "pmc_id" : "6522614",
  "score" : 0
}